Prisbind IV solution 2.5g by Nippon Boehringer Ingelheim contains Idarucizumab (genetical recombination). This injectable drug, YJ code 3399412A1027, is supplied as 2.5g in 50mL per bottle. Idarucizumab is a specific reversal agent for dabigatran, an anticoagulant.
Prisbind IV solution 2.5g
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →